← Leaderboards
Laura Marsh
Johns Hopkins University
$3,668,062
Attributed
$3,668,062
Total exposure
18
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $732.6K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$3,668,062 · 18
By mechanism
R01$2,331,873 · 1
P50$1,178,845 · 1
R29$130,365 · 1
M01$26,979 · 15
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Janice Ellen Clements$36,709,994
- Paul F Worley$57,319,879
- Mark Donowitz$42,405,980
- Elizabeth Marion Jaffee$29,780,612
- William George Nelson$34,555,726
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchParkinson DiseaseSourceParkinson'S DiseaseMotorResearch PersonnelResourcesInstitutionPerformanceFunctional DisorderPathologic ProcessAffectFundingNeurodegenerative DisordersResponseNeuropathologyDesignLongitudinal Human StudyMorbidity - Disease RateEpilepsyGrantQuality Of LifeComputer Retrieval Of Information On Scientific Projects Database
Grant awards (34)
Methods of Optimal Depression Detection in Parkinson's$295,713
R01 · FY2009 · MH · contact PI
Methods of Optimal Depression Detection in Parkinson's$158,665
R01 · FY2009 · MH · contact PI
Methods of Optimal Depression Detection in Parkinson's$474,999
R01 · FY2008 · MH · contact PI
Clinical Core$257,562
P50 · FY2008 · NS · contact PI
Clinical Core$258,534
P50 · FY2007 · NS · contact PI
LONGITUDINAL STUDIES OF PARKINSON'S DISEASE$1,762
M01 · FY2007 · RR · contact PI
TRIAL OF MEMANTINE FOR THE TREATMENT OF PARKINSON'S$1,275
M01 · FY2007 · RR · contact PI
EXECUTIVE DYSFUNCTION/PARKINSON' S DISEASE$900
M01 · FY2007 · RR · contact PI
SAD-PD$788
M01 · FY2007 · RR · contact PI
DNA REPOSITORY FOR PATIENTS WITH PARKINSON'S DISEASE$564
M01 · FY2007 · RR · contact PI
Methods of Optimal Depression Detection in Parkinson's$480,450
R01 · FY2006 · MH · contact PI
Clinical Core$227,121
P50 · FY2006 · NS · contact PI
LONGITUDINAL STUDIES OF PARKINSON'S DISEASE$5,891
M01 · FY2006 · RR · contact PI
EXECUTIVE DYSFUNCTION/PARKINSON' S DISEASE$5,069
M01 · FY2006 · RR · contact PI
TRIAL OF MEMANTINE FOR THE TREATMENT OF PARKINSON'S$2,740
M01 · FY2006 · RR · contact PI
SAD-PD$274
M01 · FY2006 · RR · contact PI
Methods of Optimal Depression Detection in Parkinson's$469,664
R01 · FY2005 · MH
Clinical Core$221,032
P50 · FY2005 · NS
LONGITUDINAL STUDIES OF PARKINSON'S DISEASE$4,985
M01 · FY2005 · RR
EXECUTIVE DYSFUNCTION/PARKINSON'S DISEASE$249
M01 · FY2005 · RR
Methods of Optimal Depression Detection in Parkinson's$452,382
R01 · FY2004 · MH
Clinical Core$214,596
P50 · FY2004 · NS
Longitudinal Studies of Parkinson's Disease$1,880
M01 · FY2004 · RR
OLANZAPINE FOR PSYCHOSIS IN PARKINSON'S DISEASE/DEMENTIA$0
M01 · FY2002 · RR
LONGITUDINAL STUDIES OF PARKINSON'S DISEASE$0
M01 · FY2002 · RR
EPILEPSY AS NEUROLOGICAL MODEL OF SCHIZOPHRENIA$0
M01 · FY2002 · RR
OLANZAPINE FOR PSYCHOSIS IN PARKINSON'S DISEASE/DEMENTIA$0
M01 · FY2001 · RR
LONGITUDINAL STUDIES OF PARKINSON'S DISEASE$0
M01 · FY2001 · RR
EPILEPSY AS NEUROLOGICAL MODEL OF SCHIZOPHRENIA$0
M01 · FY2001 · RR
EPILEPSY AS A NEUROLOGICAL MODEL OF SCHIZOPHRENIA$130,365
R29 · FY2000 · MH
EPILEPSY AS A NEUROLOGICAL MODEL OF SCHIZOPHRENIA$602
M01 · FY2000 · RR
OLANZAPINE FOR PSYCHOSIS IN PARKINSON'S DISEASE/DEMENTIA$0
M01 · FY2000 · RR
EPILEPSY AS NEUROLOGICAL MODEL OF SCHIZOPHRENIA$0
M01 · FY2000 · RR
LONGITUDINAL STUDIES OF PARKINSON'S DISEASE$0
M01 · FY2000 · RR